在MASLD中的表观遗传调节 - 对于治疗点发现的洞察力
Jan H Britsemmer1,2,3, Nuria Lopez Alcantara2,3,4, Henriette Kirchner1,2,3
1Department for Epigenetics & Metabolism, Institute of Human Genetics, University of Lübeck, Lübeck, Germany.
Epigenomics
|February 25, 2026
概括
与肥胖相关的代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及表观遗传变化,破坏肝功能. 了解这些空间表观遗传变化是开发这种常见肝病的新疗法的关键.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 代谢功能障碍相关的脂肪性肝病 (MASLD) 是最常见的慢性肝病,与肥胖症密切相关.
- 治疗选择有限,强调需要了解MASLD的分子机制.
- 表观遗传调节对肝功能至关重要,但在MASLD中失调.
研究的目的:
- 审查表观遗传学在MASLD病变发生中的作用.
- 探索沿肝脏周门-周中心轴的空间表观遗传变化.
- 讨论微RNA,细胞外囊泡以及对MASLD的潜在表观遗传疗法.
主要方法:
- 文献综述侧重于MASLD中的表观遗传机制.
- 分析空间表观遗传变化,包括染色质可访问性和microRNA活性.
- 检查非编码RNA和细胞外囊泡的作用.
主要成果:
- 表观遗传失调,包括DNA甲基化和基因组修饰,驱动MASLD的进展.
- 空间表观遗传变化破坏了肝脏中特定区域的代谢专业化.
- 微RNA和细胞外囊泡有助于MASLD中的全身代谢功能障碍.
结论:
- 表观遗传机制,特别是空间变化,对于MASLD的发展和进展至关重要.
- 针对表观遗传途径为MASLD提供了有前途的治疗策略.
- 对空间表观遗传学和非编码RNA的进一步研究对于MASLD治疗至关重要.
更多相关视频
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
10.5K
09:44High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
10.0K
相关概念视频
Master Transcription Regulators
7.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Pharmacogenomics: Identification of New Drug Targets
49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
Epigenetic Regulation
34.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.0K
Regulation of Expression at Multiple Steps
1.4K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.4K
